rxstatShortages › Metoprolol

Metoprolol shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Metoprolol products are in shortage in Canada (4 of 37 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2026.
Products affected
4 / 37
In shortage since
Aug 7, 2015
Est. full return
Dec 31, 2026
Reports on file
154
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
JAMP-METOPROLOL-L
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02356821 · since Jan 12, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-METOPROLOL-L
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02356848 · since Jan 12, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-METOPROLOL-L
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02356848 · since Jan 12, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
METOPROLOL
50MG · TABLET · SANIS HEALTH INC
DIN 02350394 · since Sep 3, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-METOPROLOL SR
200MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02285177 · since Aug 7, 2015, no end estimate · Disruption of the manufacture of the drug.
Anticipated
METOPROLOL
100MG · TABLET · SANIS HEALTH INC
DIN 02350408 · Disruption of the manufacture of the drug.
Resolved
APO-METOPROLOL
100MG · TABLET · APOTEX INC
DIN 00618640 · ended Mar 19, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-METOPROLOL
100MG · TABLET · TEVA CANADA LIMITED
DIN 00648043 · ended Dec 3, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-METOPROLOL
100MG · TABLET · APOTEX INC
DIN 00618640 · ended Oct 9, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-METOPROLOL
50MG · TABLET · TEVA CANADA LIMITED
DIN 00648035 · ended Oct 8, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-METOPROLOL
50MG · TABLET · TEVA CANADA LIMITED
DIN 00648035 · ended Oct 8, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP-METOPROLOL-L
50MG · TABLET · JAMP PHARMA CORPORATION
DIN 02356821 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Metoprolol is currently affected by 4 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, SANIS HEALTH INC, APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Metoprolol is classified under “BETA BLOCKING AGENTS” (ATC C07AB).

Recent changes

Common questions

When will Metoprolol be back in stock in Canada?

The latest manufacturer estimate is Dec 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Metoprolol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (beta blocking agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.